Subscribe

Serum Granulysin and Soluble Fas Ligand in Patients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis

Specialty:

Dermatology
Clinical Pharmacology

Objective:

ICD-10:

Description:

An increase in the serum concentration of granulysin or soluble Fas ligand (sFasL) is seen in patients with Steven-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The rise in these proteins is not seen in most other drug-related skin disorders.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone